Events ❯ Conferences ❯ Medical Conferences ❯ Alzheimer's Association International Conference
The acquisition delivers a marketed oral acromegaly therapy, with a late‑stage ACTH antagonist joining Vertex and signaling a push beyond its cystic fibrosis business.
